Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prem Soman

Showing results (151-160 of 173) with videos related to

Pageof 18
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 26, 2020
Guidance and Best Practices for Reestablishment of Non-Emergent Care in Nuclear Cardiology Laboratories During the Coronavirus Disease 2019 (COVID-19) Pandemic: An Information Statement from ASNC, IAEA, and SNMMIHicham Skali, Venkatesh L Murthy, Diana Paez, et al.
Journal of the American College of Cardiology|March 12, 2025
Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid CardiomyopathyDaniel P Judge, Kevin M Alexander, Francesco Cappelli, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 26, 2020
Guidance and best practices for reestablishment of non-emergent care in nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An information statement from ASNC, IAEA, and SNMMI : Endorsed by the Infectious Diseases Society of AmericaHicham Skali, Venkatesh L Murthy, Diana Paez, et al.
The New England Journal of Medicine|January 10, 2024
Efficacy and Safety of Acoramidis in Transthyretin Amyloid CardiomyopathyJulian D Gillmore, Daniel P Judge, Francesco Cappelli, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|November 8, 2017
Myocardial perfusion imaging: Lessons learned and work to be done-updateAmi E Iskandrian, Vasken Dilsizian, Ernest V Garcia, et al.
Journal of the American College of Cardiology|May 21, 2025
Early Increase in Serum Transthyretin by Acoramidis Independently Predicts Improved Survival in TTR Amyloid CardiomyopathyMathew S Maurer, Daniel P Judge, Julian D Gillmore, et al.
Future Cardiology|December 12, 2025
A plain language review of the ATTRibute-CM study: efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathyJulian D Gillmore, Daniel P Judge, Francesco Cappelli, et al.
Journal of Cardiac Failure|June 10, 2026
Efficacy of Acoramidis in Transthyretin Amyloid Cardiomyopathy With and Without Atrial Fibrillation: Results From ATTRibute-CMBrett W Sperry, Ahmad Masri, Kevin M Alexander, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 1, 2025
American Society of Nuclear Cardiology quality metrics for cardiac amyloid radionuclide imagingFadi G Hage, Jamieson M Bourque, Shivda Pandey, et al.
Journal of the American College of Cardiology|January 12, 2019
ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and the Society of Thoracic SurgeonsJohn U Doherty, Smadar Kort, Roxana Mehran, et al.
Pageof 18

Showing results (151-160 of 173) with videos related to

Sort By:
Pageof 18
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 26, 2020
Guidance and Best Practices for Reestablishment of Non-Emergent Care in Nuclear Cardiology Laboratories During the Coronavirus Disease 2019 (COVID-19) Pandemic: An Information Statement from ASNC, IAEA, and SNMMIHicham Skali, Venkatesh L Murthy, Diana Paez, et al.
Journal of the American College of Cardiology|March 12, 2025
Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid CardiomyopathyDaniel P Judge, Kevin M Alexander, Francesco Cappelli, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 26, 2020
Guidance and best practices for reestablishment of non-emergent care in nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An information statement from ASNC, IAEA, and SNMMI : Endorsed by the Infectious Diseases Society of AmericaHicham Skali, Venkatesh L Murthy, Diana Paez, et al.
The New England Journal of Medicine|January 10, 2024
Efficacy and Safety of Acoramidis in Transthyretin Amyloid CardiomyopathyJulian D Gillmore, Daniel P Judge, Francesco Cappelli, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|November 8, 2017
Myocardial perfusion imaging: Lessons learned and work to be done-updateAmi E Iskandrian, Vasken Dilsizian, Ernest V Garcia, et al.
Journal of the American College of Cardiology|May 21, 2025
Early Increase in Serum Transthyretin by Acoramidis Independently Predicts Improved Survival in TTR Amyloid CardiomyopathyMathew S Maurer, Daniel P Judge, Julian D Gillmore, et al.
Future Cardiology|December 12, 2025
A plain language review of the ATTRibute-CM study: efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathyJulian D Gillmore, Daniel P Judge, Francesco Cappelli, et al.
Journal of Cardiac Failure|June 10, 2026
Efficacy of Acoramidis in Transthyretin Amyloid Cardiomyopathy With and Without Atrial Fibrillation: Results From ATTRibute-CMBrett W Sperry, Ahmad Masri, Kevin M Alexander, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 1, 2025
American Society of Nuclear Cardiology quality metrics for cardiac amyloid radionuclide imagingFadi G Hage, Jamieson M Bourque, Shivda Pandey, et al.
Journal of the American College of Cardiology|January 12, 2019
ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and the Society of Thoracic SurgeonsJohn U Doherty, Smadar Kort, Roxana Mehran, et al.
Pageof 18